ARCHIVES

“Critical Issues” Include How U.S. NCI Spends Its Money. “Catastrophic” Cutback In Canada

This article is from The Cancer Letter archive.

Vol. 02 No. 20 | May 14, 1976

Download PDF Visit The Full Archive

Related Articles

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

April 28, 1995

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976

NLMs Grateful MED Aids Data Searches

March 21, 1986

Abstracts Of Papers From ASCO Meeting

April 7, 1978